共 113 条
[31]
Polito C(2000)Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis J Rheumatol 27 1073-1081
[32]
Strano CG(1999)Bisphosphonates: from the laboratory to the clinic and back again Bone 25 97-106
[33]
Rea L(1996)Intravenous administration of alendronate counteracts the in vivo effects of glucocorticoids on bone remodelling Calcif Tissue Int 58 166-169
[34]
Rabinovich EC(2000)Intravenous pamidronate in juvenile osteoporosis Arch Dis Child 83 143-145
[35]
Varamos S(1999)Expanding role of bisphosphonate therapy in children J Pediatr 134 264-267
[36]
Ansell BM(1992)Epi- and metaphyseal changes in children causes by administration of bisphosphonates Radiology 184 249-254
[37]
Reeve J(1997)Long-term effects of bisphosphonates on the growing skeleton: studies of young patients with severe osteoporosis Medicine (Baltimore) 76 266-283
[38]
Warady BD(1998)Cyclic administration of pamidronate in children with severe osteogenesis imperfecta N Engl J Med 339 947-952
[39]
Lindsley CB(2000)Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children Arthritis Rheum 43 1960-1966
[40]
Robinson RG(undefined)undefined undefined undefined undefined-undefined